Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
14,230,053
-
Share change
-
+7,322,035
-
Total reported value
-
$23,053,314
-
Price per share
-
$1.62
-
Number of holders
-
40
-
Value change
-
+$11,898,392
-
Number of buys
-
29
-
Number of sells
-
5
Institutional Holders of ZOSANO PHARMA CORP - COM NEW (ZSAN) as of Q3 2020
As of 30 Sep 2020,
ZOSANO PHARMA CORP - COM NEW (ZSAN) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,230,053 shares.
The largest 10 holders included
VANGUARD GROUP INC, Aisling Capital Management LP, MORGAN STANLEY, MORGAN JESS S & CO INC, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., CAAS CAPITAL MANAGEMENT LP, Sio Capital Management, LLC, Qube Research & Technologies Ltd, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
40
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.